Jiangsu GDK Biotechnology Co Ltd Working Capital to Net Assets Ratio
Jiangsu GDK Biotechnology Co Ltd working capital to net assets ratio. Jiangsu GDK Biotechnology Co Ltd (688670) has a Working Capital to Net Assets ratio of 9.8% as of March 2026. Working capital of CN¥105.62 Million (current assets of CN¥307.64 Million minus current liabilities of CN¥202.02 Million) is measured against net assets of CN¥1.08 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Jiangsu GDK Biotechnology Co Ltd (2017–2025)
Working capital to net assets ratio of Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025. This chart shows how Jiangsu GDK Biotechnology Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 9.8%, reflecting working capital of CN¥105.62 Million against net assets of CN¥1.08 Billion CNY. See operational self-sufficiency of Jiangsu GDK Biotechnology Co Ltd to measure how many days the company can operate on defensive assets alone.
Jiangsu GDK Biotechnology Co Ltd Working Capital to Net Assets Ratio by Year (2017–2025)
Jiangsu GDK Biotechnology Co Ltd working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Jiangsu GDK Biotechnology Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 688670 total asset value.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 10.4% | CN¥114.00 Million | CN¥1.10 Billion | CN¥355.66 Million | CN¥241.66 Million | ▼ -18.7 pp |
| 2024 | 29.1% | CN¥371.70 Million | CN¥1.28 Billion | CN¥582.58 Million | CN¥210.88 Million | ▼ -7.0 pp |
| 2023 | 36.1% | CN¥494.91 Million | CN¥1.37 Billion | CN¥722.24 Million | CN¥227.34 Million | ▼ -8.3 pp |
| 2022 | 44.4% | CN¥648.52 Million | CN¥1.46 Billion | CN¥951.02 Million | CN¥302.50 Million | ▼ -13.6 pp |
| 2021 | 58.0% | CN¥848.02 Million | CN¥1.46 Billion | CN¥1.07 Billion | CN¥221.68 Million | ▲ +52.4 pp |
| 2020 | 5.7% | CN¥13.71 Million | CN¥242.50 Million | CN¥522.79 Million | CN¥509.07 Million | ▼ -357.2 pp |
| 2019 | 362.8% | CN¥-393.22 Million | CN¥-108.38 Million | CN¥95.34 Million | CN¥488.56 Million | ▼ -51.0 pp |
| 2018 | 413.8% | CN¥-369.71 Million | CN¥-89.34 Million | CN¥13.17 Million | CN¥382.88 Million | ▼ -120.3 pp |
| 2017 | 534.1% | CN¥-327.57 Million | CN¥-61.33 Million | CN¥13.25 Million | CN¥340.82 Million | — |